Department of Cardiovascular Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
Department of Respiratory and Critical Care Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
Medicine (Baltimore). 2023 Mar 17;102(11):e33301. doi: 10.1097/MD.0000000000033301.
Thyroid dysfunction plays an important role in the development of cardiovascular disease. However, its relationship with venous thromboembolism (VTE) remains unclear. We performed a meta-analysis of published cohort and case-control studies to investigate the association between thyroid dysfunction and VTE comprehensively.
Three reviewers independently searched EMbase, PubMed, China national knowledge infrastructure, and Cochrane Library databases for relevant articles from the time of database establishment to 01 October 2022 and identified all studies on thyroid dysfunction and VTE as studies of interest. Of the 2418 publications retrieved, we identified 10 articles with 15 studies that met our selection criteria. Pooled ORs and 95% confidence intervals were calculated using fixed- or random-effect models.
We pooled 8 studies by a fixed-effect model, which suggested an increased risk of VTE in patients with (subclinical) hyperthyroidism (OR 1.33, 95% CI: 1.29-1.38). In the other 7 studies on patients with (subclinical) hypothyroidism, the risk was similarly increased when pooled by a random-effect model (OR 1.52, 95% CI: 1.23-1.89). After sensitivity analysis and risk of bias analysis, the risk of VTE was still increased in both (subclinical) hyperthyroidism (OR 1.322, 95% CI: 1.278-1.368) and (subclinical) hypothyroidism (OR 1.74, 95% CI: 1.41-2.16).
Patients with thyroid dysfunction have an increased risk of VTE. Therefore, it is recommended to perform thyroid function screening routinely in patients at high risk of VTE.
甲状腺功能障碍在心血管疾病的发展中起着重要作用。然而,其与静脉血栓栓塞症(VTE)的关系尚不清楚。我们对已发表的队列研究和病例对照研究进行了荟萃分析,以全面研究甲状腺功能障碍与 VTE 之间的关系。
三位审稿人独立检索了 EMbase、PubMed、中国知网和 Cochrane Library 数据库,从数据库建立时间到 2022 年 10 月 1 日,检索了所有关于甲状腺功能障碍和 VTE 的相关文章,并将所有这些文章都视为研究对象。在检索到的 2418 篇文献中,我们确定了 10 篇符合入选标准的文章,共 15 项研究。使用固定效应模型或随机效应模型计算合并后的 OR 和 95%置信区间。
我们通过固定效应模型合并了 8 项研究,结果表明,亚临床甲状腺功能亢进症(subclinical hyperthyroidism)患者发生 VTE 的风险增加(OR 1.33,95%CI:1.29-1.38)。在另外 7 项亚临床甲状腺功能减退症患者的研究中,通过随机效应模型合并后,风险同样增加(OR 1.52,95%CI:1.23-1.89)。在进行敏感性分析和偏倚风险分析后,亚临床甲状腺功能亢进症(OR 1.322,95%CI:1.278-1.368)和亚临床甲状腺功能减退症(OR 1.74,95%CI:1.41-2.16)患者的 VTE 风险仍然增加。
甲状腺功能障碍患者发生 VTE 的风险增加。因此,建议对 VTE 高危患者常规进行甲状腺功能筛查。